Are Janus Kinase (JAK) Inhibitors Beneficial in the Treatment of Androgenic Alopecia?

    Fiore Casale, Katerina Yale, Natasha Atanaskova Mesinkovska
    TLDR JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.
    The study investigated the effects of Janus kinase inhibitors (JAKi) on androgenetic alopecia (AGA) in 18 men treated for various inflammatory skin conditions. Over an average treatment duration of 66 weeks, no improvement in AGA was observed, although hair loss did not worsen. This suggests that while JAKi may not stimulate hair regrowth in AGA, they could potentially protect against further hair loss. The study's limitations include a small sample size and lack of histologic analysis. Further long-term studies are needed to fully understand the role of JAKi in treating different types of alopecia.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    4 / 4 results

    Related Research

    3 / 3 results